H1B Report
Side-by-side comparison

GlaxoSmithKline LLC vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
GlaxoSmithKline LLC
PARank #FEIN 23-1099050
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricGlaxoSmithKline LLCWIPRO LIMITED
Total filings73372,392
Certified %83.22%91.61%
Denied %0.41%0.37%
Withdrawn %2.05%1.37%
Cert-withdrawn %14.32%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePANJ

Outcomes — GlaxoSmithKline LLC

DOL case-status mix.

Outcome breakdown: Certified 83.2%, Cert-withdrawn 14.3%, Withdrawn 2.1%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified83.2%
Cert-withdrawn14.3%
Withdrawn2.1%
Denied0.4%
Certified83.2%
Cert-withdrawn14.3%
Withdrawn2.1%
Denied0.4%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

GlaxoSmithKline LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201023
FY201135
FY201248
FY201330
FY201424
FY201547
FY201660
FY201754
FY201855
FY201986
FY202031
FY202140
FY202217
FY202338
FY202459
FY202550
FY202636
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — GlaxoSmithKline LLC

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.